These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 10726183)

  • 21. Delivery of biotherapeutics by inhalation aerosol.
    Niven RW
    Crit Rev Ther Drug Carrier Syst; 1995; 12(2-3):151-231. PubMed ID: 9501969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhalation Devices.
    Moroni-Zentgraf P; Usmani OS; Halpin DMG
    Can Respir J; 2018; 2018():5642074. PubMed ID: 30319720
    [No Abstract]   [Full Text] [Related]  

  • 23. [The administration of aerosols in a nebulizer: the pros and cons].
    Vendrell M; de Gracia J
    Arch Bronconeumol; 1997; 33 Suppl 2():23-6. PubMed ID: 9480025
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment protocol for juvenile tuberculosis. Sociedad Española de Neumología Pediátrica. Juvenile Tuberculosis Working Group].
    An Esp Pediatr; 1998 Jan; 48(1):89-97. PubMed ID: 9542235
    [No Abstract]   [Full Text] [Related]  

  • 25. Consensus statement: aerosols and delivery devices. American Association for Respiratory Care.
    Dolovich MA; MacIntyre NR; Anderson PJ; Camargo CA; Chew N; Cole CH; Dhand R; Fink JB; Gross NJ; Hess DR; Hickey AJ; Kim CS; Martonen TB; Pierson DJ; Rubin BK; Smaldone GC
    Respir Care; 2000 Jun; 45(6):589-96. PubMed ID: 10894452
    [No Abstract]   [Full Text] [Related]  

  • 26. Carrier-based strategies for targeting protein and peptide drugs to the lungs.
    Cryan SA
    AAPS J; 2005 Mar; 7(1):E20-41. PubMed ID: 16146340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Modern methods of inhalation therapy of respiratory diseases].
    Zaitsev AA; Kharitonov MA
    Voen Med Zh; 2015 Jun; 336(6):20-4. PubMed ID: 26442311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A respiratory product for children--development and submission experiences.
    Leiner S
    Int J Pharm; 2014 Aug; 469(2):263-4. PubMed ID: 24560645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Guidelines for monitoring late-onset Pompe disease.Sociedad Española de Medicina Interna (SEMI), Sociedad Española de Neurología (SEN) y Sociedad Española de Neumología y CirugíaTorácica (SEPAR)].
    Gutiérrez-Rivas E; Illa I; Pascual-Pascual SI; Pérez-López J; Vílchez-Padilla JJ; Bautista-Lorite J; Barrot E; López de Munain A; ; ;
    Rev Neurol; 2015 Apr; 60(7):321-8. PubMed ID: 25806482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drugs for asthma and COPD.
    Treat Guidel Med Lett; 2013 Aug; 11(132):75-86; quiz following 86. PubMed ID: 23896773
    [No Abstract]   [Full Text] [Related]  

  • 31. [Good practice for aerosol therapy by nebulisation].
    Dautzenberg B; Becquemin MH; Chaumuzeau JP; Diot P;
    Rev Mal Respir; 2007 Jun; 24(6):751-7. PubMed ID: 17632434
    [No Abstract]   [Full Text] [Related]  

  • 32. A Proposed In Vitro Method to Assess Effects of Inhaled Particles on Lung Surfactant Function.
    Sørli JB; Da Silva E; Bäckman P; Levin M; Thomsen BL; Koponen IK; Larsen ST
    Am J Respir Cell Mol Biol; 2016 Mar; 54(3):306-11. PubMed ID: 26524226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pulmonary effect of inhaled furosemide in ventilated infants with severe bronchopulmonary dysplasia.
    Prabhu VG
    Pediatrics; 1997 Sep; 100(3 Pt 1):420-1. PubMed ID: 9304111
    [No Abstract]   [Full Text] [Related]  

  • 34. Metered-dose inhalers, dry powder inhalers, and transitions.
    Fink JB
    Respir Care; 2000 Jun; 45(6):623-35. PubMed ID: 10894455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies of the human oropharyngeal airspaces using magnetic resonance imaging IV--the oropharyngeal retention effect for four inhalation delivery systems.
    Burnell PK; Asking L; Borgström L; Nichols SC; Olsson B; Prime D; Shrubb I
    J Aerosol Med; 2007; 20(3):269-81. PubMed ID: 17894534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TB in the elderly: clinical features and outcomes.
    Tabernero E; Rodrigo T; Garros J; Altube L; Garay E; Medina JF; Rodríguez J; Ortiz N; Gullón JA; García-García JM
    Int J Tuberc Lung Dis; 2022 Sep; 26(9):842-849. PubMed ID: 35996280
    [No Abstract]   [Full Text] [Related]  

  • 37. Breathing easier: addressing the challenges of aerosolizing medications to infants and preschoolers.
    Goralski JL; Davis SD
    Respir Med; 2014 Aug; 108(8):1069-74. PubMed ID: 25012949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modeling breath-enhanced jet nebulizers to estimate pulmonary drug deposition.
    Wee WB; Leung K; Coates AL
    J Aerosol Med Pulm Drug Deliv; 2013 Dec; 26(6):387-96. PubMed ID: 23509934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Guidelines for aerosol devices in infants, children and adults: which to choose, why and how to achieve effective aerosol therapy.
    Ari A; Fink JB
    Expert Rev Respir Med; 2011 Aug; 5(4):561-72. PubMed ID: 21859275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting drugs to the lungs. Proceedings of a workshop. Bagshot, Surrey, United Kingdom, June 1997.
    Respir Med; 1997 Nov; 91 Suppl A():1-41. PubMed ID: 9490455
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.